Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer

16 Oct 2020

Abstract excerpt

BACKGROUND: Kidney cancer is one of the most common cancers in the world. It is necessary to clarify its underlying mechanism and find its prognostic biomarkers. Current studies showed that SHMT2 may be participated in several kinds of cancer. METHODS: Our studies investigated the expression of SHMT2 in kidney cancer by Oncomine, Human Protein Atlas database and ULCAN database. Meanwhile, we found its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33066813
DOI: 10.1186/s40659-020-00314-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancerPMID 33066813Read ↗

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder CancerSemantic proximity Read ↗

Expression Patterns and Prognostic Value of RUNX Genes in Kidney CancerSemantic proximity Read ↗

Expression patterns and prognostic value of RUNX genes in kidney cancerSemantic proximity Read ↗

Expression and prognostic significance of MT1 isoforms in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of AGXT2, SHMT1, and ACO2 as important biomarkers of acute kidney injury by WGCNASemantic proximity Read ↗

p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Semantic proximity Read ↗

Interaction Analysis of SHMT1/2 Gene Variants with HCC in Chinese PatientsSemantic proximity Read ↗

VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneySemantic proximity Read ↗

GHITM regulates malignant phenotype and sensitivity to PD-1 blockade of renal cancer cells via Notch signalling.Semantic proximity Read ↗

Succinate dehydrogenase A deficient renal cell carcinoma: A rare renal tumor distinct from typical Succinate dehydrogenase deficient renal cell carcinoma.Semantic proximity Read ↗

Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumorSemantic proximity Read ↗

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.